Joseph J. Echevarria Elected To Pfizer's Board Of Directors
Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately.
PRESS RELEASE
NEW YORK--(
)--Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately. Mr. Echevarria also was appointed to the Audit, Regulatory and Compliance and Science and Technology Committees of Pfizer’s Board.
Mr. Echevarria, 58, retired as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional services, in August 2014. He had been with the firm for 36 years and served in various leadership roles, including Deputy Managing Partner, Southeast Region Audit Managing Partner, U.S. Managing Partner and Chief Operating Officer. He was appointed CEO in 2011.
Mr. Echevarria serves as a Director of The Bank of New York Mellon Corporation. He is a member of the President’s Export Council and the Presidential Commission on Election Administration and also serves as Chair of President Obama’s My Brother’s Keeper Alliance. He serves on the Board of Trustees of the University of Miami.
“We are pleased to have Joe Echevarria join Pfizer’s Board of Directors. His expertise in international business and leadership as well as his financial acumen will be an asset to Pfizer’s Board and to the company,” stated Ian Read, Pfizer’s chairman and chief executive officer. “With the addition of Joe to our Board, Pfizer and its shareholders will continue to benefit from a breadth and diversity of experience.”
